PloS one

journal of clinical medicine

annals of translational medicine

PLoS genetics

critical care medicine

IEEE Transactions on Neural Networks and Learning Systems

ieee transactions on visualization and computer graphics

Frontiers in oncology

The Journal of infectious diseases

[1] Clinical significance of the immune cell landscape in hepatocellular carcinoma patients with different degrees of fibrosis.

[2] selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis b virus-infected patients

[3] Quasispecies pattern of hepatitis B virus predicts hepatocellular carcinoma using deep-sequencing and machine learning.

[4] The role of ecological niche evolution on diversification patterns of birds distinctly distributed between the Amazonia and Atlantic rainforests.

[5] Quantitative analysis questions the role of MeCP2 as a global regulator of alternative splicing.

[6] Early Prediction of Sepsis From Clinical Data Using Ratio and Power-Based Features.

[7] Clustering Analysis via Deep Generative Models With Mixture Models.

[8] Concept Factorization With Local Centroids.

[9] Visual Analysis of Discrimination in Machine Learning.

[10] HypoML: Visual Analysis for Hypothesis-based Evaluation of Machine Learning Models.

[11] Visual Analytics for Temporal Hypergraph Model Exploration.

[12] HyperTendril: Visual Analytics for User-Driven Hyperparameter Optimization of Deep Neural Networks.

[13] PipelineProfiler: A Visual Analytics Tool for the Exploration of AutoML Pipelines.

[14] Explainable Matrix - Visualization for Global and Local Interpretability of Random Forest Classification Ensembles.

[15] heat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type i

[16] ras-related associated with diabetes gene acts as a suppressor and inhibits warburg effect in hepatocellular carcinoma

[17] analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients

[18] Performance and Safety of a Reflux-Control Microcatheter Used to Perform DEB-TACE with LUMI Beads in HCC Patients: Preliminary Experience.

[19] Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

[20] Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

[21] Hepatocellular carcinoma (HCC) patients listed in short wait regions remain advantaged for liver transplant (LT) following 2015 HCC policy change.